Document Detail


Follicular Thyroid Carcinoma Arising after Hematopoietic Stem Cell Transplantation in a Child with Pleuropulmonary Blastoma.
MedLine Citation:
PMID:  22356448     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: Pleuropulmonary blastoma (PPB) is a rare and aggressive intrathoracic neoplasm and is associated with other dysplastic or neoplastic conditions. The prognosis, especially of type II (cystic and solid) and type III (solid) PPB, is poor. High-dose chemotherapy (HDC) and hematopoietic stem cell transplantation (HSCT) have been attempted to improve survival rates. We report the development of follicular thyroid carcinoma in a girl who was treated at a young age for PPB. Summary: A 23-month-old girl was evaluated for a clinical diagnosis of pneumonia and found to have a mass in the left lung which grew rapidly. It was removed and diagnosed as a PPB. At age two, she was referred to our hospital for further treatment. She received an adjuvant chemotherapy over six months but developed a recurred mass in her back at age 4.3 years. After removal of mass, she was given a salvage chmotherapy followed by HDC and HSCT but not radiation treatment between 4.4 and 4.9 years of age. At the age of seven, after two years without treatment she presented with multiple thyroid nodules in both lobes that steadily grew over the next two years. At age nine, she underwent total thyroidectomy, which revealed invasive follicular carcinoma. She has remained without clinical evidence of thyroid cancer for one year since surgery. Radiation therapy was not administered because of concerns of causing another malignancy. A literature search combined with the present case indicated that, of the five living patients who were treated with HDC and HSCT, three developed follicular thyroid carcinoma. Conclusions: The high prevalence (3/5, 60%) of follicular thyroid carcinoma in patients with PPB who were treated with HDC and HSCT is striking, suggesting that in patients with PPB either HDC or HSCT contribute to the development of thyroid cancer. Clinicians should be advised of the high risk of thyroid carcinoma occurrence when HDC and HSCT are being contemplated in children with PPB.
Authors:
Seung Han Shin; Jong-Hyung Yoon; Meong Hi Son; Su-Jin Kim; Seog-Yun Park; Hyun Young Kim; Hyung-Sung Lee; Hyeon Jin Park; Byung-Kiu Park
Related Documents :
22739598 - Beyond politics: new medical concerns for contraceptive users.
22500858 - How we manage prostate biopsy and prostate cancer therapy in men with haemophilia.
22295038 - The content of cadmium, cobalt and nickel in laryngeal carcinoma.
17043648 - Tissue transglutaminase expression promotes cell attachment, invasion and survival in b...
10663718 - Interventional mri of the breast: minimally invasive therapy.
15687688 - The insulin-like growth factor (igf) family and breast cancer.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-22
Journal Detail:
Title:  Thyroid : official journal of the American Thyroid Association     Volume:  -     ISSN:  1557-9077     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9104317     Medline TA:  Thyroid     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Goyang-si, Korea, Republic of; revival421@empal.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Photoinduced Energy Transfer in Bichromophoric Pyrene-PPV Oligomer Systems: The Role of Flexible Don...
Next Document:  Norwegian home care in transition - heading for accountability, off-loading responsibilities.